Health ❯ Healthcare ❯ Clinical Trials

Phase III Trials

Efficacy Studies MATTERHORN Trial TULIP-SC Trial DESTINY-Breast05 Trial KOMET Trial TROPION-Breast02 Patient Outcomes Daraxonrasib Giredestrant Trials ASPEN Trial

3 ARTICLES

3w ago

EU Regulators Back AstraZeneca’s Trixeo for Asthma

European regulators will now decide whether to add a single‑inhaler triple‑therapy option for adolescents and adults not controlled on medium‑dose ICS/LABA.

3 ARTICLES

last mo.

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

3 ARTICLES

2mo ago

Moderna mRNA Flu Vaccine Broadens B Cell and Antibody Responses

5 ARTICLES

2mo ago

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

3 ARTICLES

2mo ago

FDA Approves Belzutifan With Pembrolizumab as Adjuvant Therapy for Clear Cell Kidney Cancer

6 ARTICLES

2mo ago

Daraxonrasib Doubles Survival in Second‑Line Metastatic Pancreatic Cancer

3 ARTICLES

2mo ago

EMERALD-3 Trial Shows Progression-Free Survival Win for STRIDE Plus Lenvatinib With TACE

3 ARTICLES

2mo ago

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

3 ARTICLES

2mo ago

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

3 ARTICLES

2mo ago

FDA Approves Datroway as First‑Line Option for Immunotherapy‑Ineligible Triple‑Negative Breast Cancer

5 ARTICLES

2mo ago

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

7 ARTICLES

2mo ago

FDA Approves Baxfendy, First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

3 ARTICLES

3mo ago

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

6 ARTICLES

3mo ago

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

4 ARTICLES

3mo ago

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

10 ARTICLES

3mo ago

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

3 ARTICLES

3mo ago

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

Phase III Trials

EU Regulators Back AstraZeneca’s Trixeo for Asthma

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Moderna mRNA Flu Vaccine Broadens B Cell and Antibody Responses

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

FDA Approves Belzutifan With Pembrolizumab as Adjuvant Therapy for Clear Cell Kidney Cancer

Daraxonrasib Doubles Survival in Second‑Line Metastatic Pancreatic Cancer

EMERALD-3 Trial Shows Progression-Free Survival Win for STRIDE Plus Lenvatinib With TACE

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

FDA Approves Datroway as First‑Line Option for Immunotherapy‑Ineligible Triple‑Negative Breast Cancer

Never miss stories about

Phase III Trials

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

FDA Approves Baxfendy, First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

Moderna’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

Never miss stories about

Phase III Trials